Fountain Therapeutics
First-in-class therapies for diseases caused by aging
San Francisco Bay Area, United States · Founded 2018
- Headquarters
- San Francisco Bay Area, California
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- fountaintx.com
- Last Round
- Extension RoundNov 2021
About
Fountain Therapeutics is a clinical-stage biopharmaceutical company discovering and developing first-in-class therapies for diseases and conditions caused by aging. The company's AI-driven biology platform identifies targets connecting aging biology to chronic degenerative diseases, with lead programs in skin atrophy and sarcopenia. Fountain is backed by Khosla Ventures, Lilly, Nan Fung Life Sciences, and Alexandria Venture Investments.
Summary
Fountain Therapeutics is a Biotech company based in San Francisco Bay Area, United States, founded in 2018. Its most recent funding was an Extension Round round in Nov 2021.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...